Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE Highlights
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Creative Biolabs, as a pioneering service provider in the domain of antibody discovery and immunotherapy, boasts extensive expertise garnered over the years. We are excited to introduce our cutting-edge platform tailored to offer a γδ T cell receptor (TCR) T cell discovery service with therapeutic applications. This technology empowers patients to harness their T-cells to combat and eliminate tumor cells and infected cells.
Gamma delta (γδ) T cells represent a unique subset of T lymphocytes that differ from the more common αβ T cells in terms of their T cell receptor (TCR) structure. This structural difference endows γδ T cells with distinctive properties and functions.
Within the spectrum of TCRs, there exist two main types: αβ TCR and γδ TCR. γδ TCR-T cells typically constitute a small proportion of peripheral blood lymphocytes, they play a crucial role in human immune defense. When the physiological state undergoes changes, γδ T cells can effectively migrate and eliminate tumor cells without relying on antigen-presenting cell activation or lymphoid system cloning and expansion. This, in turn, triggers normal antigen presentation in the lymphoid system and activates a systemic immune response. The crux of γδ TCR's cancer cell recognition lies in identifying unique signal molecules expressed on their surface.
Fig.1 Enhance γδ T Cell Anti-Tumor Activity.1
We provide expert, cutting-edge services to clients worldwide, guiding them towards successful project completion. It is our commitment to advance your projects and expedite progress toward clinical trials through the utilization of our advanced technologies, platforms, and resources. For more information, please don't hesitate to reach out to us, and we will respond promptly.
Reference
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
